Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer

Indoleamine 2,3-dioxygenase (IDO) is a tryptophan-catabolising enzyme inducing immune tolerance. The present study aimed to investigate IDO expression and its prognostic significance in endometrial cancer. Indoleamine 2,3-dioxygenase expression in endometrial cancer tissues (n=80) was immunohistoche...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ino, K, Yoshida, N, Kajiyama, H, Shibata, K, Yamamoto, E, Kidokoro, K, Takahashi, N, Terauchi, M, Nawa, A, Nomura, S, Nagasaka, T, Takikawa, O, Kikkawa, F
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2006
Matèries:
Molecular Diagnostics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360726/
https://ncbi.nlm.nih.gov/pubmed/17117179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603477
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars